+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Pseudoangiomatous stromal hyperplasia (PASH). A mammary stromal tumor with myofibroblastic differentiation

Pseudoangiomatous stromal hyperplasia (PASH). A mammary stromal tumor with myofibroblastic differentiation

American Journal of Surgical Pathology 19(3): 270-277

Pseudoangiomatous stromal hyperplasia (PASH) is frequently a microscopic incidental finding in breast biopsies performed for benign or malignant disease. However, it may also produce a mass lesion. We reviewed PASH seen first as a tumor in 40 women aged 14 to 67 years (mean, 37 years). All but one lesion were clinically palpable. The exceptional tumor was found by mammography. The mass, typically unilateral, was usually diagnosed clinically as a fibroadenoma. Most specimens contained a well-circumscribed tumor with a firm white-gray cut surface. In six cases, there was no discrete gross lesion in the surgical specimen. Microscopically, there was a spectrum of pathological stromal changes ranging from classical PASH with anastomosing slit-shaped spaces outlined by flat, bland spindle cells to more proliferative lesions composed of bundles of plump spindle cells that obscured the underlying pseudoangiomatous architecture in the most florid lesions. The spindle cells were vimentin and CD34 positive and factor VIII negative. In more cellular fascicular lesions, the stromal cells acquired desmin and actin positivity. These immunohistochemical features were consistent with myofibroblastic histogenesis of PASH. Reactivity for progesterone receptor (PR) typically exceeded estrogen receptor (ER) in the nuclei of stromal and glandular cells. In most lesions, the nuclei of stromal spindle cells were ER negative. The majority of the patients were treated by excisional biopsy. One lesion, incompletely excised, spontaneously regressed. One patient had bilateral mastectomies. Follow-up was 0.6-11 years (mean, 4.5 years). Five patients had ipsilateral recurrences, and two had subsequent contralateral PASH. The morphological spectrum of cellular proliferation and staining qualities indicates that the myofibroblast plays a major role in the histogenesis of PASH. The pathogenesis of PASH remains uncertain, but aberrant reactivity of myofibroblasts to endogenous or exogenous hormones is likely to be an important factor. Simple excision is adequate treatment initially and for infrequent recurrences, Diffuse PASH occasionally presents a difficult management problem that may necessitate mastectomy.

(PDF emailed within 1 workday: $29.90)

Accession: 044082242

Download citation: RISBibTeXText

PMID: 7872425

Related references

Pseudoangiomatous stromal hyperplasia may be a mammary stromal tumor with myofibroblasitc differentiation. Advances in Anatomic Pathology 3(1): 44-45, 1996

Pseudoangiomatous stromal hyperplasia (PASH) of the mammary gland: report of a case. Surgery Today 38(4): 340-343, 2008

Nodular myofibroblastic stromal hyperplasia of the mammary gland as an accurate name for pseudoangiomatous stromal hyperplasia of the mammary gland. Breast Journal 8(5): 290-293, 2002

Pseudoangiomatous stromal hyperplasia (PASH) of the breast with foci of morphologic malignancy: a case of PASH with malignant transformation?. International Journal of Surgical Pathology 18(6): 564-569, 2008

Does Identifying Whether Pseudoangiomatous Stromal Hyperplasia (PASH) Is Focal or Diffuse on Core Biopsy Correlate With a PASH Nodule on Excision?. International Journal of Surgical Pathology 25(4): 292-297, 2016

Pseudoangiomatous stromal hyperplasia (PASH). Radiologia 48(3): 164, 177, 2006

Inflammatory Myofibroblastic Tumor of the Breast Coexisting with Pseudoangiomatous Stromal Hyperplasia. Journal of Breast Health 12(4): 171-173, 2016

Pseudoangiomatous stromal hyperplasia (PASH): a brief review. International Journal of Surgery 9(1): 20-22, 2011

A case of nodular pseudoangiomatous stromal hyperplasia (PASH). Breast Cancer 13(4): 349-353, 2006

Pseudoangiomatous stromal hyperplasia (PASH) of the breast: intraductal appearance. Journal of Obstetrics and Gynaecology Research 35(4): 816-818, 2009

Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a series of 24 patients. Breast Journal 18(3): 242-247, 2012

Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a clinicopathological study of 79 cases. International Journal of Surgical Pathology 20(1): 54-58, 2012

Pseudoangiomatous stromal hyperplasia (PASH) tumors on core needle biopsy (CNB): Is excision necessary?. 2007

Pseudoangiomatous stromal hyperplasia (PASH) causing massive breast enlargement: MRI findings. Breast Journal 18(6): 600-601, 2013

Pseudoangiomatous stromal hyperplasia (PASH) presenting as axillary lump: case report and review of the literature. Il Giornale di Chirurgia 39(6): 378-382, 2018